nodes	percent_of_prediction	percent_of_DWPC	metapath
Folic Acid—ABCC3—Vincristine—sarcoma	0.13	0.164	CbGbCtD
Folic Acid—ABCC3—Etoposide—sarcoma	0.119	0.15	CbGbCtD
Folic Acid—ABCG2—Dactinomycin—sarcoma	0.0867	0.11	CbGbCtD
Folic Acid—ABCC3—Doxorubicin—sarcoma	0.0813	0.103	CbGbCtD
Folic Acid—ABCG2—Mitoxantrone—sarcoma	0.0776	0.098	CbGbCtD
Folic Acid—CYP2E1—Dacarbazine—sarcoma	0.0713	0.0901	CbGbCtD
Folic Acid—CYP2E1—Mitoxantrone—sarcoma	0.0553	0.0699	CbGbCtD
Folic Acid—ABCG2—Vincristine—sarcoma	0.0534	0.0674	CbGbCtD
Folic Acid—ABCG2—Etoposide—sarcoma	0.0489	0.0618	CbGbCtD
Folic Acid—CYP2E1—Etoposide—sarcoma	0.0349	0.0441	CbGbCtD
Folic Acid—ABCG2—Doxorubicin—sarcoma	0.0334	0.0422	CbGbCtD
Folic Acid—GGH—Fluoropyrimidine Activity—SMUG1—sarcoma	0.00631	0.11	CbGpPWpGaD
Folic Acid—FOLR2—Folate Metabolism—HBA1—sarcoma	0.00608	0.106	CbGpPWpGaD
Folic Acid—FOLR3—Folate Metabolism—HBA1—sarcoma	0.00608	0.106	CbGpPWpGaD
Folic Acid—ABCC11—mammary gland—sarcoma	0.00577	0.0426	CbGeAlD
Folic Acid—FOLR3—hematopoietic system—sarcoma	0.00569	0.042	CbGeAlD
Folic Acid—FOLR2—mammary gland—sarcoma	0.0052	0.0383	CbGeAlD
Folic Acid—ABCC11—embryo—sarcoma	0.00394	0.0291	CbGeAlD
Folic Acid—SLC25A32—myometrium—sarcoma	0.00371	0.0274	CbGeAlD
Folic Acid—FOLR2—myometrium—sarcoma	0.00369	0.0272	CbGeAlD
Folic Acid—FOLR3—bone marrow—sarcoma	0.00365	0.0269	CbGeAlD
Folic Acid—SLC25A32—seminal vesicle—sarcoma	0.00336	0.0248	CbGeAlD
Folic Acid—FOLR2—seminal vesicle—sarcoma	0.00333	0.0246	CbGeAlD
Folic Acid—SLC25A32—hematopoietic system—sarcoma	0.00319	0.0235	CbGeAlD
Folic Acid—FOLR2—hematopoietic system—sarcoma	0.00317	0.0234	CbGeAlD
Folic Acid—FOLR3—testis—sarcoma	0.00312	0.023	CbGeAlD
Folic Acid—FOLR2—connective tissue—sarcoma	0.00305	0.0225	CbGeAlD
Folic Acid—GGH—myometrium—sarcoma	0.00284	0.0209	CbGeAlD
Folic Acid—SLC25A32—smooth muscle tissue—sarcoma	0.00281	0.0207	CbGeAlD
Folic Acid—SLC46A1—seminal vesicle—sarcoma	0.00261	0.0192	CbGeAlD
Folic Acid—GGH—seminal vesicle—sarcoma	0.00256	0.0189	CbGeAlD
Folic Acid—MTHFR—mammary gland—sarcoma	0.00253	0.0187	CbGeAlD
Folic Acid—SLC46A1—hematopoietic system—sarcoma	0.00248	0.0183	CbGeAlD
Folic Acid—SLC25A32—cardiac atrium—sarcoma	0.00242	0.0179	CbGeAlD
Folic Acid—SLC25A32—uterus—sarcoma	0.00241	0.0178	CbGeAlD
Folic Acid—FOLR2—cardiac atrium—sarcoma	0.0024	0.0177	CbGeAlD
Folic Acid—FOLR2—uterus—sarcoma	0.00239	0.0176	CbGeAlD
Folic Acid—GGH—smooth muscle tissue—sarcoma	0.00215	0.0158	CbGeAlD
Folic Acid—GGH—skin of body—sarcoma	0.00212	0.0156	CbGeAlD
Folic Acid—SLC25A32—tendon—sarcoma	0.00211	0.0156	CbGeAlD
Folic Acid—FOLR2—tendon—sarcoma	0.00209	0.0155	CbGeAlD
Folic Acid—MTHFR—Folate-Alcohol and Cancer Pathway—CREB1—sarcoma	0.00209	0.0366	CbGpPWpGaD
Folic Acid—SLC25A32—bone marrow—sarcoma	0.00204	0.0151	CbGeAlD
Folic Acid—FOLR2—bone marrow—sarcoma	0.00203	0.015	CbGeAlD
Folic Acid—FOLR2—Folate Metabolism—IL2—sarcoma	0.00198	0.0345	CbGpPWpGaD
Folic Acid—FOLR3—Folate Metabolism—IL2—sarcoma	0.00198	0.0345	CbGpPWpGaD
Folic Acid—ABCC11—testis—sarcoma	0.00193	0.0142	CbGeAlD
Folic Acid—GGH—uterus—sarcoma	0.00184	0.0136	CbGeAlD
Folic Acid—ABCC11—liver—sarcoma	0.00182	0.0134	CbGeAlD
Folic Acid—SLC25A32—testis—sarcoma	0.00175	0.0129	CbGeAlD
Folic Acid—SLC46A1—lymphoid tissue—sarcoma	0.00174	0.0129	CbGeAlD
Folic Acid—FOLR2—testis—sarcoma	0.00173	0.0128	CbGeAlD
Folic Acid—ABCC4—Ectoderm Differentiation—PTPRB—sarcoma	0.00171	0.0299	CbGpPWpGaD
Folic Acid—GGH—Fluoropyrimidine Activity—TP53—sarcoma	0.00167	0.0293	CbGpPWpGaD
Folic Acid—SLC25A32—liver—sarcoma	0.00165	0.0122	CbGeAlD
Folic Acid—FOLR2—liver—sarcoma	0.00164	0.0121	CbGeAlD
Folic Acid—SLC46A1—tendon—sarcoma	0.00164	0.0121	CbGeAlD
Folic Acid—GGH—tendon—sarcoma	0.00161	0.0119	CbGeAlD
Folic Acid—SLC46A1—Folate Metabolism—HBA1—sarcoma	0.0016	0.028	CbGpPWpGaD
Folic Acid—GGH—bone marrow—sarcoma	0.00156	0.0115	CbGeAlD
Folic Acid—MTHFR—hematopoietic system—sarcoma	0.00154	0.0114	CbGeAlD
Folic Acid—SLC46A1—testis—sarcoma	0.00136	0.01	CbGeAlD
Folic Acid—GGH—testis—sarcoma	0.00134	0.00985	CbGeAlD
Folic Acid—MTHFR—Fluoropyrimidine Activity—SMUG1—sarcoma	0.00132	0.0231	CbGpPWpGaD
Folic Acid—SLC46A1—liver—sarcoma	0.00128	0.00947	CbGeAlD
Folic Acid—FOLR3—Folate Metabolism—TP53—sarcoma	0.00127	0.0222	CbGpPWpGaD
Folic Acid—FOLR2—Folate Metabolism—TP53—sarcoma	0.00127	0.0222	CbGpPWpGaD
Folic Acid—SLC25A32—lymph node—sarcoma	0.00127	0.00935	CbGeAlD
Folic Acid—GGH—liver—sarcoma	0.00126	0.00932	CbGeAlD
Folic Acid—FOLR2—lymph node—sarcoma	0.00126	0.00928	CbGeAlD
Folic Acid—MTHFR—Vitamin B12 Metabolism—HBA1—sarcoma	0.00119	0.0208	CbGpPWpGaD
Folic Acid—ABCC3—hematopoietic system—sarcoma	0.00115	0.0085	CbGeAlD
Folic Acid—MTHFR—lymphoid tissue—sarcoma	0.00108	0.008	CbGeAlD
Folic Acid—SLC46A1—lymph node—sarcoma	0.000984	0.00726	CbGeAlD
Folic Acid—MTHFR—Folate Metabolism—HBA1—sarcoma	0.000968	0.0169	CbGpPWpGaD
Folic Acid—GGH—lymph node—sarcoma	0.000968	0.00714	CbGeAlD
Folic Acid—ABCC4—hematopoietic system—sarcoma	0.000951	0.00702	CbGeAlD
Folic Acid—ABCC3—Fluoropyrimidine Activity—SMUG1—sarcoma	0.00085	0.0149	CbGpPWpGaD
Folic Acid—MTHFR—testis—sarcoma	0.000844	0.00623	CbGeAlD
Folic Acid—ABCC4—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000799	0.014	CbGpPWpGaD
Folic Acid—MTHFR—liver—sarcoma	0.000798	0.00589	CbGeAlD
Folic Acid—ABCG2—myometrium—sarcoma	0.000782	0.00577	CbGeAlD
Folic Acid—MTHFR—Selenium Micronutrient Network—HBA1—sarcoma	0.000769	0.0134	CbGpPWpGaD
Folic Acid—ABCC4—uterus—sarcoma	0.000719	0.0053	CbGeAlD
Folic Acid—ABCC4—Ectoderm Differentiation—PAX3—sarcoma	0.00071	0.0124	CbGpPWpGaD
Folic Acid—ABCG2—seminal vesicle—sarcoma	0.000707	0.00521	CbGeAlD
Folic Acid—ABCC3—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	0.000672	0.0117	CbGpPWpGaD
Folic Acid—CYP2E1—Folate-Alcohol and Cancer Pathway—CREB1—sarcoma	0.000665	0.0116	CbGpPWpGaD
Folic Acid—Sensitisation—Epirubicin—sarcoma	0.000646	0.0423	CcSEcCtD
Folic Acid—ABCG2—HIF-2-alpha transcription factor network—FLT1—sarcoma	0.000633	0.0111	CbGpPWpGaD
Folic Acid—ABCC3—testis—sarcoma	0.000632	0.00466	CbGeAlD
Folic Acid—ABCC4—tendon—sarcoma	0.00063	0.00465	CbGeAlD
Folic Acid—CYP2E1—seminal vesicle—sarcoma	0.000612	0.00451	CbGeAlD
Folic Acid—MTHFR—lymph node—sarcoma	0.000612	0.00451	CbGeAlD
Folic Acid—ABCC4—bone marrow—sarcoma	0.00061	0.0045	CbGeAlD
Folic Acid—Sensitisation—Doxorubicin—sarcoma	0.000598	0.0391	CcSEcCtD
Folic Acid—ABCC3—liver—sarcoma	0.000597	0.00441	CbGeAlD
Folic Acid—ABCG2—Fluoropyrimidine Activity—SMUG1—sarcoma	0.000586	0.0102	CbGpPWpGaD
Folic Acid—CYP2E1—hematopoietic system—sarcoma	0.000581	0.00429	CbGeAlD
Folic Acid—ABCC4—Platelet degranulation—VEGFC—sarcoma	0.000544	0.00951	CbGpPWpGaD
Folic Acid—ABCC4—testis—sarcoma	0.000521	0.00385	CbGeAlD
Folic Acid—SLC46A1—Folate Metabolism—IL2—sarcoma	0.000521	0.00911	CbGpPWpGaD
Folic Acid—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFC—sarcoma	0.000518	0.00906	CbGpPWpGaD
Folic Acid—ABCG2—uterus—sarcoma	0.000507	0.00374	CbGeAlD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—NPM1—sarcoma	0.000498	0.0087	CbGpPWpGaD
Folic Acid—ABCC4—liver—sarcoma	0.000493	0.00364	CbGeAlD
Folic Acid—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	0.000472	0.00825	CbGpPWpGaD
Folic Acid—ABCC3—lymph node—sarcoma	0.000458	0.00338	CbGeAlD
Folic Acid—ABCG2—bone marrow—sarcoma	0.00043	0.00318	CbGeAlD
Folic Acid—SLC25A32—Disease—TLE1—sarcoma	0.000427	0.00747	CbGpPWpGaD
Folic Acid—CYP2E1—lymphoid tissue—sarcoma	0.000409	0.00302	CbGeAlD
Folic Acid—SLC25A32—Disease—NPM1—sarcoma	0.000385	0.00673	CbGpPWpGaD
Folic Acid—CYP2E1—tendon—sarcoma	0.000385	0.00284	CbGeAlD
Folic Acid—ABCC4—lymph node—sarcoma	0.000378	0.00279	CbGeAlD
Folic Acid—ABCG2—testis—sarcoma	0.000368	0.00272	CbGeAlD
Folic Acid—ABCG2—HIF-2-alpha transcription factor network—KDR—sarcoma	0.000365	0.00638	CbGpPWpGaD
Folic Acid—MTHFR—Fluoropyrimidine Activity—TP53—sarcoma	0.000352	0.00615	CbGpPWpGaD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—CXCR4—sarcoma	0.000351	0.00614	CbGpPWpGaD
Folic Acid—ABCG2—liver—sarcoma	0.000348	0.00257	CbGeAlD
Folic Acid—SLC46A1—Folate Metabolism—TP53—sarcoma	0.000335	0.00585	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—ENO2—sarcoma	0.000334	0.00583	CbGpPWpGaD
Folic Acid—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	0.000329	0.00575	CbGpPWpGaD
Folic Acid—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	0.000324	0.00566	CbGpPWpGaD
Folic Acid—CYP2E1—testis—sarcoma	0.000319	0.00235	CbGeAlD
Folic Acid—MTHFR—Folate Metabolism—IL2—sarcoma	0.000314	0.0055	CbGpPWpGaD
Folic Acid—CYP2E1—liver—sarcoma	0.000301	0.00222	CbGeAlD
Folic Acid—Depression—Vincristine—sarcoma	0.000283	0.0186	CcSEcCtD
Folic Acid—SLC25A32—Disease—PLCG1—sarcoma	0.000283	0.00495	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—ENO2—sarcoma	0.000279	0.00488	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—HBA1—sarcoma	0.000278	0.00485	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—CXCR4—sarcoma	0.000272	0.00475	CbGpPWpGaD
Folic Acid—ABCG2—lymph node—sarcoma	0.000267	0.00197	CbGeAlD
Folic Acid—Bronchospasm—Etoposide—sarcoma	0.000254	0.0166	CcSEcCtD
Folic Acid—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	0.000251	0.00439	CbGpPWpGaD
Folic Acid—Erythema—Thiotepa—sarcoma	0.000251	0.0164	CcSEcCtD
Folic Acid—Erythema—Dactinomycin—sarcoma	0.000249	0.0163	CcSEcCtD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—VEGFC—sarcoma	0.000241	0.00422	CbGpPWpGaD
Folic Acid—SLC25A32—Metabolism—PLCG1—sarcoma	0.000237	0.00414	CbGpPWpGaD
Folic Acid—Ill-defined disorder—Dactinomycin—sarcoma	0.000231	0.0151	CcSEcCtD
Folic Acid—Agitation—Thiotepa—sarcoma	0.00023	0.0151	CcSEcCtD
Folic Acid—ABCC3—Fluoropyrimidine Activity—TP53—sarcoma	0.000226	0.00394	CbGpPWpGaD
Folic Acid—Malaise—Dactinomycin—sarcoma	0.000224	0.0147	CcSEcCtD
Folic Acid—Convulsion—Thiotepa—sarcoma	0.000217	0.0142	CcSEcCtD
Folic Acid—Erythema—Mitoxantrone—sarcoma	0.000216	0.0142	CcSEcCtD
Folic Acid—ABCC4—Fluoropyrimidine Activity—TP53—sarcoma	0.000212	0.00371	CbGpPWpGaD
Folic Acid—Dysgeusia—Mitoxantrone—sarcoma	0.000212	0.0139	CcSEcCtD
Folic Acid—Discomfort—Dactinomycin—sarcoma	0.000209	0.0137	CcSEcCtD
Folic Acid—Confusional state—Thiotepa—sarcoma	0.000206	0.0135	CcSEcCtD
Folic Acid—Agitation—Vincristine—sarcoma	0.000204	0.0134	CcSEcCtD
Folic Acid—MTHFR—Folate Metabolism—TP53—sarcoma	0.000202	0.00353	CbGpPWpGaD
Folic Acid—ABCG2—HIF-2-alpha transcription factor network—VEGFA—sarcoma	0.000201	0.00351	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—FOXO1—sarcoma	0.000201	0.00351	CbGpPWpGaD
Folic Acid—Ill-defined disorder—Mitoxantrone—sarcoma	0.000201	0.0131	CcSEcCtD
Folic Acid—SLC25A32—Disease—PDGFRB—sarcoma	0.000201	0.00351	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—PDGFRA—sarcoma	0.000197	0.00345	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—TLE1—sarcoma	0.000196	0.00343	CbGpPWpGaD
Folic Acid—Malaise—Mitoxantrone—sarcoma	0.000195	0.0128	CcSEcCtD
Folic Acid—Anorexia—Thiotepa—sarcoma	0.000195	0.0128	CcSEcCtD
Folic Acid—Anorexia—Dactinomycin—sarcoma	0.000193	0.0127	CcSEcCtD
Folic Acid—Convulsion—Vincristine—sarcoma	0.000192	0.0126	CcSEcCtD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—CREB1—sarcoma	0.000188	0.00329	CbGpPWpGaD
Folic Acid—Convulsion—Mitoxantrone—sarcoma	0.000187	0.0123	CcSEcCtD
Folic Acid—Discomfort—Mitoxantrone—sarcoma	0.000182	0.0119	CcSEcCtD
Folic Acid—Anaphylactic shock—Vincristine—sarcoma	0.000181	0.0119	CcSEcCtD
Folic Acid—Dyspepsia—Thiotepa—sarcoma	0.00018	0.0118	CcSEcCtD
Folic Acid—Confusional state—Mitoxantrone—sarcoma	0.000178	0.0117	CcSEcCtD
Folic Acid—Decreased appetite—Thiotepa—sarcoma	0.000178	0.0116	CcSEcCtD
Folic Acid—SLC46A1—Disease—NPM1—sarcoma	0.000177	0.00309	CbGpPWpGaD
Folic Acid—Anaphylactic shock—Mitoxantrone—sarcoma	0.000177	0.0116	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Thiotepa—sarcoma	0.000177	0.0116	CcSEcCtD
Folic Acid—Decreased appetite—Dactinomycin—sarcoma	0.000176	0.0115	CcSEcCtD
Folic Acid—Dysgeusia—Etoposide—sarcoma	0.000176	0.0115	CcSEcCtD
Folic Acid—Anorexia—Vincristine—sarcoma	0.000173	0.0113	CcSEcCtD
Folic Acid—ABCC4—Hemostasis—TEK—sarcoma	0.00017	0.00296	CbGpPWpGaD
Folic Acid—Feeling abnormal—Thiotepa—sarcoma	0.000168	0.011	CcSEcCtD
Folic Acid—Anorexia—Mitoxantrone—sarcoma	0.000168	0.011	CcSEcCtD
Folic Acid—Feeling abnormal—Dactinomycin—sarcoma	0.000167	0.0109	CcSEcCtD
Folic Acid—Ill-defined disorder—Etoposide—sarcoma	0.000167	0.0109	CcSEcCtD
Folic Acid—Malaise—Etoposide—sarcoma	0.000162	0.0106	CcSEcCtD
Folic Acid—Decreased appetite—Vincristine—sarcoma	0.000158	0.0103	CcSEcCtD
Folic Acid—Dyspnoea—Mitoxantrone—sarcoma	0.000157	0.0103	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Vincristine—sarcoma	0.000157	0.0102	CcSEcCtD
Folic Acid—Convulsion—Etoposide—sarcoma	0.000156	0.0102	CcSEcCtD
Folic Acid—ABCG2—Fluoropyrimidine Activity—TP53—sarcoma	0.000156	0.00272	CbGpPWpGaD
Folic Acid—Dyspepsia—Mitoxantrone—sarcoma	0.000155	0.0102	CcSEcCtD
Folic Acid—ABCC4—Hemostasis—ANGPT2—sarcoma	0.000155	0.00271	CbGpPWpGaD
Folic Acid—Decreased appetite—Mitoxantrone—sarcoma	0.000153	0.01	CcSEcCtD
Folic Acid—SLC46A1—Disease—ENO2—sarcoma	0.000153	0.00268	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—KIT—sarcoma	0.000153	0.00268	CbGpPWpGaD
Folic Acid—Discomfort—Etoposide—sarcoma	0.000151	0.00991	CcSEcCtD
Folic Acid—CYP2E1—Tryptophan metabolism—MDM2—sarcoma	0.000149	0.00261	CbGpPWpGaD
Folic Acid—Confusional state—Etoposide—sarcoma	0.000148	0.0097	CcSEcCtD
Folic Acid—Anaphylactic shock—Etoposide—sarcoma	0.000147	0.00962	CcSEcCtD
Folic Acid—Abdominal distension—Epirubicin—sarcoma	0.000146	0.00954	CcSEcCtD
Folic Acid—SLC25A32—Disease—CREB1—sarcoma	0.000146	0.00255	CbGpPWpGaD
Folic Acid—Feeling abnormal—Mitoxantrone—sarcoma	0.000146	0.00953	CcSEcCtD
Folic Acid—Pruritus—Thiotepa—sarcoma	0.000145	0.00947	CcSEcCtD
Folic Acid—Anorexia—Etoposide—sarcoma	0.00014	0.00917	CcSEcCtD
Folic Acid—ABCC4—Platelet degranulation—VEGFA—sarcoma	0.000138	0.00242	CbGpPWpGaD
Folic Acid—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	0.000138	0.00241	CbGpPWpGaD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—JUN—sarcoma	0.000135	0.00237	CbGpPWpGaD
Folic Acid—Abdominal distension—Doxorubicin—sarcoma	0.000135	0.00883	CcSEcCtD
Folic Acid—ABCC4—Response to elevated platelet cytosolic Ca2+—VEGFA—sarcoma	0.000132	0.0023	CbGpPWpGaD
Folic Acid—Dyspnoea—Etoposide—sarcoma	0.000131	0.00857	CcSEcCtD
Folic Acid—SLC46A1—Disease—PLCG1—sarcoma	0.00013	0.00227	CbGpPWpGaD
Folic Acid—Rash—Thiotepa—sarcoma	0.000129	0.00844	CcSEcCtD
Folic Acid—Dermatitis—Thiotepa—sarcoma	0.000129	0.00843	CcSEcCtD
Folic Acid—SLC46A1—Metabolism—ENO2—sarcoma	0.000128	0.00224	CbGpPWpGaD
Folic Acid—Rash—Dactinomycin—sarcoma	0.000128	0.00838	CcSEcCtD
Folic Acid—Decreased appetite—Etoposide—sarcoma	0.000128	0.00836	CcSEcCtD
Folic Acid—SLC46A1—Metabolism—HBA1—sarcoma	0.000127	0.00223	CbGpPWpGaD
Folic Acid—Gastrointestinal disorder—Etoposide—sarcoma	0.000127	0.0083	CcSEcCtD
Folic Acid—SLC46A1—Disease—CXCR4—sarcoma	0.000125	0.00218	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—VEGFC—sarcoma	0.000124	0.00217	CbGpPWpGaD
Folic Acid—Nausea—Thiotepa—sarcoma	0.000121	0.00795	CcSEcCtD
Folic Acid—Feeling abnormal—Etoposide—sarcoma	0.000121	0.00792	CcSEcCtD
Folic Acid—SLC25A32—Disease—MDM2—sarcoma	0.000121	0.00211	CbGpPWpGaD
Folic Acid—Nausea—Dactinomycin—sarcoma	0.000121	0.00789	CcSEcCtD
Folic Acid—MTHFR—Disease—TLE1—sarcoma	0.000118	0.00207	CbGpPWpGaD
Folic Acid—ABCG2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	0.000118	0.00207	CbGpPWpGaD
Folic Acid—Rash—Vincristine—sarcoma	0.000114	0.00748	CcSEcCtD
Folic Acid—Dermatitis—Vincristine—sarcoma	0.000114	0.00748	CcSEcCtD
Folic Acid—Rash—Mitoxantrone—sarcoma	0.000111	0.00729	CcSEcCtD
Folic Acid—Dermatitis—Mitoxantrone—sarcoma	0.000111	0.00728	CcSEcCtD
Folic Acid—SLC46A1—Metabolism—PLCG1—sarcoma	0.000109	0.0019	CbGpPWpGaD
Folic Acid—Nausea—Vincristine—sarcoma	0.000108	0.00705	CcSEcCtD
Folic Acid—MTHFR—Disease—NPM1—sarcoma	0.000107	0.00187	CbGpPWpGaD
Folic Acid—Nausea—Mitoxantrone—sarcoma	0.000105	0.00687	CcSEcCtD
Folic Acid—SLC25A32—Disease—CTNNB1—sarcoma	0.000104	0.00182	CbGpPWpGaD
Folic Acid—Pruritus—Etoposide—sarcoma	0.000104	0.0068	CcSEcCtD
Folic Acid—ABCC4—Ectoderm Differentiation—CTNNB1—sarcoma	0.000102	0.00177	CbGpPWpGaD
Folic Acid—Erythema—Epirubicin—sarcoma	0.000101	0.0066	CcSEcCtD
Folic Acid—Flatulence—Epirubicin—sarcoma	9.94e-05	0.00651	CcSEcCtD
Folic Acid—Dysgeusia—Epirubicin—sarcoma	9.88e-05	0.00647	CcSEcCtD
Folic Acid—ABCC4—Hemostasis—PLCG1—sarcoma	9.78e-05	0.00171	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—SRC—sarcoma	9.4e-05	0.00164	CbGpPWpGaD
Folic Acid—Ill-defined disorder—Epirubicin—sarcoma	9.36e-05	0.00613	CcSEcCtD
Folic Acid—Erythema—Doxorubicin—sarcoma	9.33e-05	0.00611	CcSEcCtD
Folic Acid—Agitation—Epirubicin—sarcoma	9.27e-05	0.00607	CcSEcCtD
Folic Acid—Rash—Etoposide—sarcoma	9.26e-05	0.00606	CcSEcCtD
Folic Acid—Dermatitis—Etoposide—sarcoma	9.25e-05	0.00606	CcSEcCtD
Folic Acid—MTHFR—Disease—ENO2—sarcoma	9.24e-05	0.00162	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—FOXO1—sarcoma	9.22e-05	0.00161	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—PDGFRB—sarcoma	9.21e-05	0.00161	CbGpPWpGaD
Folic Acid—Flatulence—Doxorubicin—sarcoma	9.2e-05	0.00602	CcSEcCtD
Folic Acid—Dysgeusia—Doxorubicin—sarcoma	9.14e-05	0.00598	CcSEcCtD
Folic Acid—Malaise—Epirubicin—sarcoma	9.1e-05	0.00596	CcSEcCtD
Folic Acid—SLC46A1—Disease—PDGFRA—sarcoma	9.06e-05	0.00158	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—NRAS—sarcoma	9.04e-05	0.00158	CbGpPWpGaD
Folic Acid—Convulsion—Epirubicin—sarcoma	8.74e-05	0.00572	CcSEcCtD
Folic Acid—Nausea—Etoposide—sarcoma	8.72e-05	0.00571	CcSEcCtD
Folic Acid—Ill-defined disorder—Doxorubicin—sarcoma	8.66e-05	0.00567	CcSEcCtD
Folic Acid—Agitation—Doxorubicin—sarcoma	8.58e-05	0.00562	CcSEcCtD
Folic Acid—Discomfort—Epirubicin—sarcoma	8.48e-05	0.00556	CcSEcCtD
Folic Acid—SLC25A32—Disease—MYC—sarcoma	8.42e-05	0.00147	CbGpPWpGaD
Folic Acid—Malaise—Doxorubicin—sarcoma	8.42e-05	0.00551	CcSEcCtD
Folic Acid—Confusional state—Epirubicin—sarcoma	8.3e-05	0.00543	CcSEcCtD
Folic Acid—SLC25A32—Disease—EGFR—sarcoma	8.24e-05	0.00144	CbGpPWpGaD
Folic Acid—Anaphylactic shock—Epirubicin—sarcoma	8.23e-05	0.00539	CcSEcCtD
Folic Acid—ABCC4—Ectoderm Differentiation—MYC—sarcoma	8.22e-05	0.00144	CbGpPWpGaD
Folic Acid—Convulsion—Doxorubicin—sarcoma	8.09e-05	0.00529	CcSEcCtD
Folic Acid—Discomfort—Doxorubicin—sarcoma	7.85e-05	0.00514	CcSEcCtD
Folic Acid—Anorexia—Epirubicin—sarcoma	7.85e-05	0.00514	CcSEcCtD
Folic Acid—MTHFR—Disease—PLCG1—sarcoma	7.84e-05	0.00137	CbGpPWpGaD
Folic Acid—SLC25A32—Disease—KRAS—sarcoma	7.78e-05	0.00136	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—ENO2—sarcoma	7.74e-05	0.00135	CbGpPWpGaD
Folic Acid—MTHFR—Metabolism—HBA1—sarcoma	7.69e-05	0.00134	CbGpPWpGaD
Folic Acid—Confusional state—Doxorubicin—sarcoma	7.68e-05	0.00503	CcSEcCtD
Folic Acid—Anaphylactic shock—Doxorubicin—sarcoma	7.62e-05	0.00499	CcSEcCtD
Folic Acid—MTHFR—Disease—CXCR4—sarcoma	7.54e-05	0.00132	CbGpPWpGaD
Folic Acid—Dyspnoea—Epirubicin—sarcoma	7.34e-05	0.00481	CcSEcCtD
Folic Acid—Anorexia—Doxorubicin—sarcoma	7.26e-05	0.00475	CcSEcCtD
Folic Acid—Dyspepsia—Epirubicin—sarcoma	7.25e-05	0.00474	CcSEcCtD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—IL2—sarcoma	7.22e-05	0.00126	CbGpPWpGaD
Folic Acid—Decreased appetite—Epirubicin—sarcoma	7.16e-05	0.00469	CcSEcCtD
Folic Acid—Gastrointestinal disorder—Epirubicin—sarcoma	7.11e-05	0.00465	CcSEcCtD
Folic Acid—SLC46A1—Disease—KIT—sarcoma	7.03e-05	0.00123	CbGpPWpGaD
Folic Acid—Dyspnoea—Doxorubicin—sarcoma	6.79e-05	0.00445	CcSEcCtD
Folic Acid—Feeling abnormal—Epirubicin—sarcoma	6.78e-05	0.00444	CcSEcCtD
Folic Acid—Dyspepsia—Doxorubicin—sarcoma	6.71e-05	0.00439	CcSEcCtD
Folic Acid—SLC46A1—Disease—CREB1—sarcoma	6.69e-05	0.00117	CbGpPWpGaD
Folic Acid—Decreased appetite—Doxorubicin—sarcoma	6.62e-05	0.00434	CcSEcCtD
Folic Acid—SLC25A32—Disease—HRAS—sarcoma	6.61e-05	0.00116	CbGpPWpGaD
Folic Acid—Gastrointestinal disorder—Doxorubicin—sarcoma	6.58e-05	0.00431	CcSEcCtD
Folic Acid—MTHFR—Metabolism—PLCG1—sarcoma	6.57e-05	0.00115	CbGpPWpGaD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—SRC—sarcoma	6.3e-05	0.0011	CbGpPWpGaD
Folic Acid—Feeling abnormal—Doxorubicin—sarcoma	6.28e-05	0.00411	CcSEcCtD
Folic Acid—ABCC4—Platelet activation, signaling and aggregation—VEGFA—sarcoma	6.13e-05	0.00107	CbGpPWpGaD
Folic Acid—Pruritus—Epirubicin—sarcoma	5.82e-05	0.00381	CcSEcCtD
Folic Acid—MTHFR—Disease—FOXO1—sarcoma	5.57e-05	0.000973	CbGpPWpGaD
Folic Acid—MTHFR—Disease—PDGFRB—sarcoma	5.56e-05	0.000971	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—MDM2—sarcoma	5.53e-05	0.000968	CbGpPWpGaD
Folic Acid—MTHFR—Disease—PDGFRA—sarcoma	5.47e-05	0.000956	CbGpPWpGaD
Folic Acid—Pruritus—Doxorubicin—sarcoma	5.39e-05	0.00353	CcSEcCtD
Folic Acid—Rash—Epirubicin—sarcoma	5.19e-05	0.0034	CcSEcCtD
Folic Acid—Dermatitis—Epirubicin—sarcoma	5.19e-05	0.0034	CcSEcCtD
Folic Acid—ABCC3—Metabolism—ENO2—sarcoma	4.97e-05	0.000869	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—HBA1—sarcoma	4.94e-05	0.000863	CbGpPWpGaD
Folic Acid—Nausea—Epirubicin—sarcoma	4.89e-05	0.0032	CcSEcCtD
Folic Acid—Rash—Doxorubicin—sarcoma	4.8e-05	0.00314	CcSEcCtD
Folic Acid—Dermatitis—Doxorubicin—sarcoma	4.8e-05	0.00314	CcSEcCtD
Folic Acid—SLC46A1—Disease—CTNNB1—sarcoma	4.77e-05	0.000835	CbGpPWpGaD
Folic Acid—Nausea—Doxorubicin—sarcoma	4.52e-05	0.00296	CcSEcCtD
Folic Acid—SLC46A1—Disease—SRC—sarcoma	4.32e-05	0.000754	CbGpPWpGaD
Folic Acid—MTHFR—Disease—KIT—sarcoma	4.24e-05	0.000741	CbGpPWpGaD
Folic Acid—ABCC3—Metabolism—PLCG1—sarcoma	4.22e-05	0.000737	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—NRAS—sarcoma	4.15e-05	0.000726	CbGpPWpGaD
Folic Acid—MTHFR—Disease—CREB1—sarcoma	4.04e-05	0.000706	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—MYC—sarcoma	3.87e-05	0.000676	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—EGFR—sarcoma	3.78e-05	0.000661	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—IL2—sarcoma	3.72e-05	0.00065	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—KRAS—sarcoma	3.57e-05	0.000625	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—ENO2—sarcoma	3.43e-05	0.000599	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—HBA1—sarcoma	3.4e-05	0.000595	CbGpPWpGaD
Folic Acid—MTHFR—Disease—MDM2—sarcoma	3.34e-05	0.000584	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—SRC—sarcoma	3.25e-05	0.000567	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—VEGFA—sarcoma	3.16e-05	0.000553	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—NRAS—sarcoma	3.12e-05	0.000546	CbGpPWpGaD
Folic Acid—SLC46A1—Disease—HRAS—sarcoma	3.04e-05	0.000531	CbGpPWpGaD
Folic Acid—ABCG2—Metabolism—PLCG1—sarcoma	2.91e-05	0.000508	CbGpPWpGaD
Folic Acid—MTHFR—Disease—CTNNB1—sarcoma	2.88e-05	0.000504	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—KRAS—sarcoma	2.69e-05	0.00047	CbGpPWpGaD
Folic Acid—MTHFR—Disease—SRC—sarcoma	2.6e-05	0.000455	CbGpPWpGaD
Folic Acid—MTHFR—Disease—NRAS—sarcoma	2.51e-05	0.000438	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—ENO2—sarcoma	2.46e-05	0.00043	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—HBA1—sarcoma	2.44e-05	0.000427	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—TP53—sarcoma	2.39e-05	0.000418	CbGpPWpGaD
Folic Acid—MTHFR—Disease—MYC—sarcoma	2.33e-05	0.000408	CbGpPWpGaD
Folic Acid—ABCC4—Hemostasis—HRAS—sarcoma	2.28e-05	0.000399	CbGpPWpGaD
Folic Acid—MTHFR—Disease—EGFR—sarcoma	2.28e-05	0.000399	CbGpPWpGaD
Folic Acid—MTHFR—Disease—KRAS—sarcoma	2.16e-05	0.000377	CbGpPWpGaD
Folic Acid—CYP2E1—Metabolism—PLCG1—sarcoma	2.09e-05	0.000365	CbGpPWpGaD
Folic Acid—MTHFR—Disease—HRAS—sarcoma	1.83e-05	0.00032	CbGpPWpGaD
